Zobrazeno 1 - 10
of 14
pro vyhledávání: '"HG Klingemann"'
Autor:
DE Reece, JM Connors, JJ Spinelli, MJ Barnett, RN Fairey, HG Klingemann, SH Nantel, S O'Reilly, JD Shepherd, HJ Sutherland
Publikováno v:
Blood. 83:1193-1199
The optimal timing in which to use intensive chemotherapy and autologous bone marrow transplantation (BMT) in Hodgkin's disease (HD) is uncertain. In 1985, we initiated a program in which this modality was used as the initial salvage therapy in patie
Autor:
GL Phillips, DE Reece, JD Shepherd, MJ Barnett, RA Brown, DA Frei-Lahr, HG Klingemann, BJ Bolwell, JJ Spinelli, RH Herzig
Publikováno v:
Blood. 77(7)
Seventy consecutive adult patients with acute myelogenous leukemia (AML), median age 44 years, received high-dose cytarabine (3 g/m2 every 12 hours for 12 doses) followed by daunorubicin (45 mg/m2 daily for three doses) for remission induction. A sin
Autor:
Hg, Klingemann, Shoukat Dedhar
Publikováno v:
Europe PubMed Central
The receptors for fibronectin (FN-R) and vitronectin (VN-R) belong to a family of integral membrane glycoproteins known to be involved in cell- extracellular matrix and cell-cell interactions named integrins (FN-R = beta 1 integrin and VN-R = beta 3
Autor:
Bagheri, Yasin, Barati, Alireza, Aghebati‐Maleki, Ali, Aghebati‐Maleki, Leili, Yousefi, Mehdi
Publikováno v:
Cell Biology International; Jan2021, Vol. 45 Issue 1, p2-17, 16p
Autor:
Rich, Ivan N.
Publikováno v:
Journal of Perinatal Medicine; Jan1995, Vol. 23 Issue 1/2, p31-38, 8p
Publikováno v:
Seminars in Thrombosis & Hemostasis; 1996, Vol. 22 Issue 5, p419-425, 7p
Autor:
Marlar, Richard A., Neumann, Alice
Publikováno v:
Seminars in Thrombosis & Hemostasis; 1990, Vol. 16 Issue 4, p299-309, 11p
Publikováno v:
Seminars in Thrombosis & Hemostasis; 1990, Vol. 16 Issue 4, p293-298, 6p
Autor:
Levine, Mark N.
Publikováno v:
Seminars in Thrombosis & Hemostasis; 1986, Vol. 12 Issue 1, p63-66, 4p
Autor:
Griffin, John H.
Publikováno v:
Seminars in Thrombosis & Hemostasis; 1984, Vol. 10 Issue 2, p162-166, 5p